Chk2 kinase — a busy messenger (original) (raw)

• Elledge, S. J. Cell cycle checkpoints: preventing an identity crisis. Science 274, 1664?1672 (1996).
  Article CAS PubMed Google Scholar
• Weinert, T. DNA damage and checkpoint pathways: molecular anatomy and interactions with repair. Cell 94, 555?558 (1998).
  Article CAS PubMed Google Scholar
• Walworth, N. C. Cell-cycle checkpoint kinases: checking in on the cell cycle. Curr. Opin. Cell Biol. 12, 697?704 (2000).
  Article CAS PubMed Google Scholar
• Hoeijmakers, J. H. Genome maintenance mechanisms for preventing cancer. Nature 411, 366?374 (2001).
  Article CAS PubMed Google Scholar
• Rotman, G. & Shiloh, Y. The ATM gene and protein: possible roles in genome surveillance, checkpoint controls and cellular defence against oxidative stress. Cancer Surv. 29, 285?304 (1997).
  CAS PubMed Google Scholar
• Hartwell, L. H. & Kastan, M. B. Cell cycle control and cancer. Science 266, 1821?1828 (1994).
  Article CAS PubMed Google Scholar
• Hartwell, L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71, 543?546 (1992).
  Article CAS PubMed Google Scholar
• Weinert, T. Yeast checkpoint controls and relevance to cancer. Cancer Surv. 29, 109?132 (1997).
  CAS PubMed Google Scholar
• Dasika, G. K. et al. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene 18, 7883?7899 (1999).
  Article CAS PubMed Google Scholar
• Abraham, R. T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15, 2177?2196 (2001).
  Article CAS PubMed Google Scholar
• Zhou, B. B. & Elledge, S. J. The DNA damage response: putting checkpoints in perspective. Nature 408, 433?439 (2000).
  Article CAS PubMed Google Scholar
• Lowndes, N. F. & Murguia, J. R. Sensing and responding to DNA damage. Curr. Opin. Genet. Dev. 10, 17?25 (2000).
  Article CAS PubMed Google Scholar
• Durocher, D. & Jackson, S. P. DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme? Curr. Opin. Cell Biol. 13, 225?231 (2001).
  Article CAS PubMed Google Scholar
• Khanna, K. K. & Jackson, S. P. DNA double-strand breaks: signaling, repair and the cancer connection. Nature Genet. 27, 247?254 (2001).
  Article CAS PubMed Google Scholar
• Carr, A. M. Control of cell cycle arrest by the Mec1sc/Rad3sp DNA structure checkpoint pathway. Curr. Opin. Genet. Dev. 7, 93?98 (1997).
  Article CAS PubMed Google Scholar
• Murray, A. W. The genetics of cell cycle checkpoints. Curr. Opin. Genet. Dev. 5, 5?11 (1995).
  Article CAS PubMed Google Scholar
• Kastan, M. B. & Lim, D. S. The many substrates and functions of ATM. Nature Rev. Mol. Cell Biol. 1, 179?186 (2000).
  Article CAS Google Scholar
• Shiloh, Y. ATM and ATR: networking cellular responses to DNA damage. Curr. Opin. Genet. Dev. 11, 71?77 (2001).
  Article CAS PubMed Google Scholar
• Shiloh, Y. & Rotman, G. Ataxia-telangiectasia and the ATM gene: linking neurodegeneration, immunodeficiency, and cancer to cell cycle checkpoints. J. Clin. Immunol. 16, 254?260 (1996).
  Article CAS PubMed Google Scholar
• Lavin, M. F. & Shiloh, Y. The genetic defect in ataxia-telangiectasia. Annu. Rev. Immunol. 15, 177?202 (1997).
  Article CAS PubMed Google Scholar
• Rhind, N. & Russell, P. Chk1 and Cds1: linchpins of the DNA damage and replication checkpoint pathways. J. Cell Sci. 113, 3889?3896 (2000).
  CAS PubMed PubMed Central Google Scholar
• Matsuoka, S., Huang, M. & Elledge, S. J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282, 1893?1897 (1998).The cloning of human and mouse Chk2 . Together with references 23?26 , this report shows that mammalian Chk2 is a functional homologue of S. cerevisiae Rad53 and S. pombe cds1, and a downstream effector of ATM.
  Article CAS PubMed Google Scholar
• Blasina, A. et al. A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase. Curr. Biol. 9, 1?10 (1999).
  Article CAS PubMed Google Scholar
• Brown, A. L. et al. A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. Proc. Natl Acad. Sci. USA 96, 3745?3750 (1999).
  Article CAS PubMed Google Scholar
• Tominaga, K. et al. Role of human Cds1 (Chk2) kinase in DNA damage checkpoint and its regulation by p53. J. Biol. Chem. 274, 31463?31467 (1999).
  Article CAS PubMed Google Scholar
• Chaturvedi, P. et al. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 18, 4047?4054 (1999).
  Article CAS PubMed Google Scholar
• Hartwell, L. H. & Weinert, T. A. Checkpoints: controls that ensure the order of cell cycle events. Science 246, 629?634 (1989).
  Article CAS PubMed Google Scholar
• Allen, J. B., Zhou, Z., Siede, W., Friedberg, E. C. & Elledge, S. J. The SAD1/RAD53 protein kinase controls multiple checkpoints and DNA damage-induced transcription in yeast. Genes Dev. 8, 2401?2415 (1994).
  Article CAS PubMed Google Scholar
• Murakami, H. & Okayama, H. A kinase from fission yeast responsible for blocking mitosis in S phase. Nature 374, 817?819 (1995).
  Article CAS PubMed Google Scholar
• Guo, Z. & Dunphy, W. G. Response of Xenopus Cds1 in cell-free extracts to DNA templates with double-stranded ends. Mol. Biol. Cell 11, 1535?1546 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Higashitani, A. et al. Caenorhabditis elegans Chk2-like gene is essential for meiosis but dispensable for DNA repair. FEBS Lett. 485, 35?39 (2000).
  Article CAS PubMed Google Scholar
• Oishi, I. et al. Critical role of Caenorhabditis elegans homologs of Cds1 (Chk2)-related kinases in meiotic recombination. Mol. Cell. Biol. 21, 1329?1335 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• MacQueen, A. J. & Villeneuve, A. M. Nuclear reorganization and homologous chromosome pairing during meiotic prophase require C. elegans chk-2. Genes Dev. 15, 1674?1687 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Oishi, I. et al. A novel Drosophila nuclear protein serine/threonine kinase expressed in the germline during its establishment. Mech. Dev. 71, 49?63 (1998).
  Article CAS PubMed Google Scholar
• Rockmill, B. & Roeder, G. S. A meiosis-specific protein kinase homolog required for chromosome synapsis and recombination. Genes Dev. 5, 2392?2404 (1991).
  Article CAS PubMed Google Scholar
• Matsuoka, S. et al. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl Acad. Sci. USA 97, 10389?10394 (2000).This study and references 37 and 38 provide evidence for direct phosphorylation of Chk2 by the ATM and ATR kinases in vitro . ATM-dependent phosphorylation of threonine 68 was shown to be required for ionizing-radiation-induced Chk2 activation, also in vivo.
  Article CAS PubMed Google Scholar
• Melchionna, R., Chen, X. B., Blasina, A. & McGowan, C. H. Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1. Nature Cell Biol. 2, 762?765 (2000).
  Article CAS PubMed Google Scholar
• Ahn, J. Y., Schwarz, J. K., Piwnica-Worms, H. & Canman, C. E. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res. 60, 5934?5936 (2000).
  CAS PubMed Google Scholar
• Tanaka, K., Boddy, M. N., Chen, X. B., McGowan, C. H. & Russell, P. Threonine-11, phosphorylated by Rad3 and ATM in vitro, is required for activation of fission yeast checkpoint kinase Cds1. Mol. Cell. Biol. 21, 3398?3404 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Hofmann, K. & Bucher, P. The FHA domain: a putative nuclear signalling domain found in protein kinases and transcription factors. Trends Biochem. Sci. 20, 347?349 (1995).
  Article CAS PubMed Google Scholar
• Li, J., Lee, G. I., Van Doren, S. R. & Walker, J. C. The FHA domain mediates phosphoprotein interactions. J. Cell Sci. 113, 4143?4149 (2000).
  CAS PubMed Google Scholar
• Sun, Z., Hsiao, J., Fay, D. S. & Stern, D. F. Rad53 FHA domain associated with phosphorylated Rad9 in the DNA damage checkpoint. Science 281, 272?274 (1998).The original report that identifies a role for the Rad53 FHA2 domain in phosphospecific interactions between Rad9 and Rad53.
  Article CAS PubMed Google Scholar
• Li, J., Smith, G. P. & Walker, J. C. Kinase interaction domain of kinase-associated protein phosphatase, a phosphoprotein-binding domain. Proc. Natl Acad. Sci. USA 96, 7821?7826 (1999).
  Article CAS PubMed Google Scholar
• Durocher, D., Henckel, J., Fersht, A. R. & Jackson, S. P. The FHA domain is a modular phosphopeptide recognition motif. Mol. Cell 4, 387?394 (1999).
  Article CAS PubMed Google Scholar
• Durocher, D. et al. The molecular basis of FHA domain: phosphopeptide binding specificity and implications for phospho-dependent signaling mechanisms. Mol. Cell 6, 1169?1182 (2000).A detailed in vitro binding analysis, which shows that FHA domains have high affinity for phospho-threonine residues. The FHA optimal recognition motif was identified as pTXXD (in which T is threonine, D is aspartic acid and X is any amino acid).
  Article CAS PubMed Google Scholar
• Lee, C. H. & Chung, J. H. The hCds1 (Chk2)-FHA domain is essential for a chain of phosphorylation events on hCds1 that is induced by ionizing radiation. J. Biol. Chem. 276, 30537?30541 (2001).Evidence for an essential role of the Chk2 FHA domain and autophosphorylation of threonines 383 and 387 in the Chk2 activation loop for the full activation of the kinase.
  Article CAS PubMed Google Scholar
• Gilbert, C. S., Green, C. M. & Lowndes, N. F. Budding yeast Rad9 is an ATP-dependent Rad53 activating machine. Mol. Cell 8, 129?136 (2001).This study proposes an intriguing model of Rad53 activation whereby Mec1/Tel1-dependent phosphorylation of Rad9 converts the latter protein to a scaffold that brings two Rad53 molecules into close proximity.
  Article CAS PubMed Google Scholar
• Ward, I. M., Wu, X. & Chen, J. Threonine 68 of Chk2 is phosphorylated at sites of DNA strand breaks. J. Biol. Chem. (in the press).
• Bork, P. et al. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 11, 68?76 (1997).
  Article CAS PubMed Google Scholar
• Kumagai, A. & Dunphy, W. G. Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts. Mol. Cell 6, 839?849 (2000).
  Article CAS PubMed Google Scholar
• Alcasabas, A. A. et al. Mrc1 transduces signals of DNA replication stress to activate Rad53. Nature Cell Biol. 3, 958?965 (2001).This study and reference 52 indicates that in yeast, Mrc1 might serve as a replicative counterpart of Rad9 and crb2 in activation of the Rad53 and cds1 kinases, respectively.
  Article CAS PubMed Google Scholar
• Tanaka, K. & Russell, P. Mrc1 channels the DNA replication arrest signal to checkpoint kinase Cds1. Nature Cell Biol. 3, 966?972 (2001).
  Article CAS PubMed Google Scholar
• Shieh, S. Y., Ahn, J., Tamai, K., Taya, Y. & Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14, 289?300 (2000).
  CAS PubMed PubMed Central Google Scholar
• Chehab, N. H., Malikzay, A., Stavridi, E. S. & Halazonetis, T. D. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc. Natl Acad. Sci. USA 96, 13777?13782 (1999).Phosphorylation of the serine 20 residue of p53 was shown to be required for its DNA-damage-dependent stabilization. This was soon followed by identification of Chk1 and Chk2 as the kinases that mediate this phosphorylation (references 53 and 55).
  Article CAS PubMed Google Scholar
• Chehab, N. H., Malikzay, A., Appel, M. & Halazonetis, T. D. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev. 14, 278?288 (2000).
  CAS PubMed PubMed Central Google Scholar
• Vogelstein, B., Lane, D. & Levine, A. J. Surfing the p53 network. Nature 408, 307?310 (2000).
  Article CAS PubMed Google Scholar
• Ryan, K. M., Phillips, A. C. & Vousden, K. H. Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell Biol. 13, 332?337 (2001).
  Article CAS PubMed Google Scholar
• Hirao, A. et al. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287, 1824?1827 (2000).The first ? and, so far, the only ? report on Chk2 -knockout mouse embryo fibroblasts, which indicates an involvement of Chk2 in DNA-damage-dependent stabilization of p53 and G2/M checkpoint arrest.
  Article CAS PubMed Google Scholar
• Lee, J. S., Collins, K. M., Brown, A. L., Lee, C. H. & Chung, J. H. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 404, 201?204 (2000).The association with, and phosphorylation of, BRCA1 by Chk2 was identified as an important event in BRCA1-dependent DNA-damage checkpoint function.
  Article CAS PubMed Google Scholar
• Scully, R. & Livingston, D. M. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408, 429?432 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Xu, B., Kim, S. & Kastan, M. B. Involvement of BRCA1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol. Cell. Biol. 21, 3445?3450 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Y. et al. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14, 927?939 (2000).
  CAS PubMed PubMed Central Google Scholar
• Sanchez, Y. et al. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 277, 1497?1501 (1997).
  Article CAS PubMed Google Scholar
• Peng, C. Y. et al. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277, 1501?1505 (1997).
  Article CAS PubMed Google Scholar
• Zeng, Y. & Piwnica-Worms, H. DNA damage and replication checkpoints in fission yeast require nuclear exclusion of the Cdc25 phosphatase via 14-3-3 binding. Mol. Cell. Biol. 19, 7410?7419 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Graves, P. R., Lovly, C. M., Uy, G. L. & Piwnica-Worms, H. Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding. Oncogene 20, 1839?1851 (2001).
  Article CAS PubMed Google Scholar
• Falck, J., Mailand, N., Syljuåsen, R. G., Bartek, J. & Lukas, J. The ATM?Chk2?Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410, 842?847 (2001).Identification of the Chk2-mediated degradation of the Cdc25A phosphatase as a rate-limiting step in the DNA damage intra-S-phase checkpoint in response to ionizing radiation.
  Article CAS PubMed Google Scholar
• Mailand, N. et al. Rapid destruction of human Cdc25A in response to DNA damage. Science 288, 1425?1429 (2000).This report and reference 69 shows a rapid, checkpoint-dependent degradation of Cdc25A in response to ultraviolet radiation and stalled replication, respectively.
  Article CAS PubMed Google Scholar
• Molinari, M., Mercurio, C., Dominguez, J., Goubin, F. & Draetta, G. F. Human Cdc25A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Rep. 1, 71?79 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Petrini, J. H. The Mre11 complex and ATM: collaborating to navigate S phase. Curr. Opin. Cell Biol. 12, 293?296.
• Kastan, M. B. Cell cycle. Checking two steps. Nature 410, 766?767 (2001).
  Article CAS PubMed Google Scholar
• Banin, S. et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281, 1674?1677 (1998).
  Article CAS PubMed Google Scholar
• Canman, C. E. et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677?1679 (1998).
  Article CAS PubMed Google Scholar
• Maya, R. et al. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 15, 1067?1077 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Cortez, D., Wang, Y., Qin, J. & Elledge, S. J. Requirement of ATM-dependent phosphorylation of BRCA1 in the DNA damage response to double-strand breaks. Science 286, 1162?1166 (1999).
  Article CAS PubMed Google Scholar
• Tibbetts, R. S. et al. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 14, 2989?3002 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Li, S. et al. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature 406, 210?215 (2000).
  Article CAS PubMed Google Scholar
• Barlow, C. et al. ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation. Proc. Natl Acad. Sci. USA 97, 871?876 (2000).
  Article CAS PubMed Google Scholar
• Lukas, C. et al. DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biology. Cancer Res. 61, 4990?4993 (2001).This study highlights the striking differences between human CHK2 and CHK1, and reports an unexpected correlation of CHK2 expression with tissue biology.
  CAS PubMed Google Scholar
• Bartkova, J. et al. Chk2 tumour suppressor protein in human spermatogenesis and testicular germ-cell tumours. Oncogene 20, 5897?5902 (2001).
  Article CAS PubMed Google Scholar
• Flaggs, G. et al. ATM-dependent interactions of a mammalian chk1 homolog with meiotic chromosomes. Curr. Biol. 7, 977?986 (1997).
  Article CAS PubMed Google Scholar
• Kaneko, Y. et al. Cell cycle-dependent and ATM-independent expression of human Chk1 kinase. Oncogene 18, 3673?3681 (1999).
  Article CAS PubMed Google Scholar
• Bartek, J. & Lukas, J. Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr. Opin. Cell Biol. (in the press).
• Bell, D. W. et al. Heterozygous germ line hCHK2 mutations in Li?Fraumeni syndrome. Science 286, 2528?2531 (1999).The identification of germline mutations in the CHK2 gene in Li?Fraumeni families with wild-type p53, which indicates a role for CHK2 as a tumour suppressor. Subsequently, identical and additional mutations were found in sporadic cancers of different origin (references 86?88).
  Article CAS PubMed Google Scholar
• Sodha, N. et al. Screening for hCHK2 mutations. Science 289, 359 (2000).
• Haruki, N. et al. Histological type-selective, tumor-predominant expression of a novel CHK1 isoform and infrequent in vivo somatic CHK2 mutation in small cell lung cancer. Cancer Res. 60, 4689?4692 (2000).
  CAS PubMed Google Scholar
• Hofman, W.-K. et al. Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias. Leuk. Res. 25, 333?338 (2001).
  Article Google Scholar
• Vahteristo, P. et al. p53, CHK2, and CHK1 genes in Finnish families with Li?Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition. Cancer Res. 61, 5718?5722 (2001).
  CAS PubMed Google Scholar
• Falck, J. et al. Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway. Oncogene 20, 5503?5510 (2001).Evidence that the concomitant mutation of p53 and CHK2 might provide a selective advantage to tumour cells.
  Article CAS PubMed Google Scholar
• Wu, X., Webster, S. R. & Chen, J. Characterization of tumor-associated Chk2 mutations. J. Biol. Chem. 276, 2971?2974 (2001).
  Article CAS PubMed Google Scholar
• Matsuoka, S. et al. Reduced expression and impaired kinase activity of a Chk2 mutant identified in human lung cancer. Cancer Res. 61, 5362?5365 (2001).
  CAS PubMed Google Scholar
• Yao, S. L. et al. Selective radiosensitization of p53-deficient cells by caffeine-mediated activation of p34cdc2 kinase. Nature Med. 2, 1140?1143 (1996).
  Article CAS PubMed Google Scholar
• Suganuma, M., Kawabe, T., Hori, H., Funabiki, T. & Okamoto, T. Sensitization of cancer cells to DNA damage-induced cell death by specific cell cycle G2 checkpoint abrogation. Cancer Res. 59, 5887?5891 (1999).
  CAS PubMed Google Scholar
• Nghiem, P., Park, P. K., Kim, Y. Vaziri, C. & Schreiber, S. L. ATR inhibition selectively sensitizes G1 checkpoint-deficient cells to lethal premature chromatin condensation. Proc. Natl Acad. Sci. USA 98, 9092?9097 (2001).
  Article CAS PubMed Google Scholar
• Yu, L. et al. UCN-01 abrogates G2 arrest through a Cdc2-dependent pathway that is associated with inactivation of the Wee1Hu kinase and activation of the Cdc25C phosphatase. J. Biol. Chem. 273, 33455?33464 (1998).
  Article CAS PubMed Google Scholar
• Graves, P. R. et al. The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J. Biol. Chem. 275, 5600?5605 (2000).
  Article CAS PubMed Google Scholar
• Chen, M. S., Hurov, J., White, L. S., Woodford-Thomas, T. & Piwnica-Worms, H. Absence of apparent phenotype in mice lacking Cdc25C protein phosphatase. Mol. Cell. Biol. 21, 3853?3861 (2001).
  Article CAS PubMed PubMed Central Google Scholar